Working tables on Hormone Receptor positive (HR+), Human Epidermal growth factor Receptor 2 negative (HER2-) early stage breast cancer: Defining high risk of recurrence

Autor:	Zambelli, A., Gallerani, E., Garrone, O., Pedersini, R., Rota Caremoli, E., Sagrada, P., Sala, E., Cazzaniga, ME
Zdroj:	In Critical Reviews in Oncology / Hematology November 2023 191
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect